(Albany, US) DelveInsight has launched a new report on Mesothelioma Epidemiology

DelveInsight’s Mesothelioma Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Mesothelioma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Mesothelioma is a rare, aggressive form of malignant tumor that is caused by inhaled asbestos fibers and forms in the lining of the lungs, abdomen or heart. There are four primary types of mesothelioma based on tumor location are Pleural Mesothelioma (MPM), Peritoneal Mesothelioma, Pericardial Mesothelioma, and Testicular Mesothelioma. Pleural mesothelioma is a cancer of the pleura, which is the mesothelium surrounding the lungs and it is the most common type of the mesothelioma, accounting for 80 – 90% of all diagnosed cases. Because male are exposed to asbestos more often, they are more likely to be diagnosed with mesothelioma. The main risk factor for mesothelioma is exposure to asbestos. Asbestos is a group of minerals that occur naturally as bundles of tiny fibers. These fibers are found in soil and rocks in many parts of the world. When asbestos fibers in the air are inhaled, they can get into the lungs. Fibers that stay in the lungs can travel to the ends of the small airways and enter the pleural lining of the lung and chest wall.

 

Request for free sample page:- https://www.delveinsight.com/sample-request/mesothelioma-epidemiology-forecast

Mesothelioma Epidemiology Perspective by DelveInsight

The Mesothelioma epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Mesothelioma epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Mesothelioma epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Mesothelioma Epidemiology

There are four primary types of mesothelioma can be based on tumor location, wherein pleural mesothelioma and peritoneal mesothelioma are the two most common types of mesothelioma. According to secondary domain, Peritoneal disease accounts for approximately 10-20% of mesothelioma cases. According to research, around half of peritoneal mesothelioma patients who have surgery and heated chemotherapy (HIPEC) live five or more years after diagnosis. The other two forms. i.e., Pericardial Mesothelioma, and Testicular Mesothelioma observed in nearly 1% or less than 1% of cases of Mesothelioma

Key facts of the report

• The total Incident cases of Mesothelioma in the 7MM were observed to be  13,028  cases in 2017 which are estimated to decline during the study period (2017-2030)
• Mesothelioma incidence rates in most of the 7MM countries (except Spain and Japan) are in the declining trend due to reduced population wide exposure to asbestos. Among the European Countries, highest Mesothelioma incident cases observed in the UK in 2017
• According to the analysis, males are more frequently diagnosed with Mesothelioma compared to females.
• Spain accounted for the least number of incident cases, i.e., 524 cases in 2017
• United Sates accounted for nearly 3,200 mesothelioma cases for year 2017.

 

Mesothelioma Report Scope

• The Mesothelioma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Mesothelioma Epidemiology Report and Model provide an overview of the risk factors and global trends of Mesothelioma in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight about the historical and forecasted patient pool of Mesothelioma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Mesothelioma
• The report provides the segmentation of the Mesothelioma epidemiology

 

Request for free sample page:- https://www.delveinsight.com/sample-request/mesothelioma-epidemiology-forecast

Table of content

1. Key Insights

2. Executive Summary of Mesothelioma

3. Mesothelioma: Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Why should you buy this report?

• The Mesothelioma Epidemiology report will allow the user to –
• Develop business strategies by understanding the trends shaping and driving the global Mesothelioma market
• Quantify patient populations in the global Mesothelioma market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Mesothelioma therapeutics in each of the markets covered
• Understand the magnitude of Mesothelioma population by its epidemiology
• The Mesothelioma Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Related Reports

• Malignant Mesothelioma – Pipeline Insights, 2020
• Mesothelioma Market Insight, Epidemiology and Market Forecast -2030

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/